Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV‐1 envelopeMaria Castedo, Guido Kroemer, Thomas Roumier et al.|The EMBO Journal|2002Cited by 147
Toward the Discovery of Novel Anti‐HIV Drugs. Second‐Generation Inhibitors of the Cellular ATPase DDX3 with Improved Anti‐HIV Activity: Synthesis, Structure–Activity Relationship Analysis, Cytotoxicity Studies, and Target ValidationGiovanni Maga, Maurizio Botta, Emmanuel González et al.|ChemMedChem|2011Cited by 105
New Nitrogen Containing Substituents at the Indole-2-carboxamide Yield High Potent and Broad Spectrum Indolylarylsulfone HIV-1 Non-Nucleoside Reverse Transcriptase InhibitorsGiuseppe La Regina, Romano Silvestri, Antonio Coluccia et al.|Journal of Medicinal Chemistry|2012Cited by 61
Inhibition of herpes simplex virus type 1 by the CDK6 inhibitor PD-0332991 (palbociclib) through the control of SAMHD1Roger Badía, José A. Esté|Journal of Antimicrobial Chemotherapy|2015Cited by 48
Discovery of Chiral Cyclopropyl Dihydro-Alkylthio-Benzyl-Oxopyrimidine (<i>S</i>-DABO) Derivatives as Potent HIV-1 Reverse Transcriptase Inhibitors with High Activity Against Clinically Relevant MutantsMarco Radi, Maurizio Botta, Giovanni Maga et al.|Journal of Medicinal Chemistry|2009Cited by 38